Ondine Biomedical Websites
MRSA Topic
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc.
8,927,663
$
240.00
MRSAid Blog | MRSAid is a novel, non-antibiotic system for nasal bacte
MRSAid is a novel non-antibiotic therapy developed for use in hospital/long-term care settings for nasal decolonization of potentially pathogenic bacteria, including MRSA. Developed by Ondine Biomedical Inc., the global leaders in antimicrobial photodynamics, MRSAid is a valuable tool for the prevention of hospital-acq
7,613,293
$
240.00
